Haemostatic Changes in Five Patients Infected with Ebola Virus
暂无分享,去创建一个
T. Fletcher | E. Kirkman | S. Watts | B. Hunt | S. Smither | L. O’Brien | M. Lever | L. Eastaugh | T. Woolley | K. Parmar
[1] G. Ippolito,et al. Relationship Between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] J. Strong,et al. Delivering Prolonged Intensive Care to a Non-human Primate: A High Fidelity Animal Model of Critical Illness , 2017, Scientific Reports.
[3] H. ten Cate,et al. Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories , 2016, Thrombosis Journal.
[4] Dennis Williams,et al. Disseminated Intravascular Coagulation. , 2016, American journal of clinical pathology.
[5] L. Nyakarahuka,et al. How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence , 2016, BMC Infectious Diseases.
[6] Christos T. Nakas,et al. Does centrifugation matter? Centrifugal force and spinning time alter the plasma metabolome , 2016, Metabolomics.
[7] Timothy D. Flietstra,et al. Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] S. Bhagani,et al. Thromboelastography in the Management of Coagulopathy Associated With Ebola Virus Disease. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] A. Brault,et al. Prognostic Indicators for Ebola Patient Survival , 2016, Emerging infectious diseases.
[10] T. Fletcher,et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. , 2015, The Lancet. Infectious diseases.
[11] F. Salguero,et al. Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit. , 2015, The Journal of infectious diseases.
[12] Rachel S. G. Sealfon,et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. , 2014, The New England journal of medicine.
[13] Ying Zhao,et al. Effects of storage time and temperature on coagulation tests and factors in fresh plasma , 2014, Scientific Reports.
[14] M. Lackemeyer,et al. Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. , 2011, Microbes and infection.
[15] B. Lämmle,et al. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature: only a part of the story. Reply to E. J. Favaloro , 2008, Thrombosis and Haemostasis.
[16] P. Jahrling,et al. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. , 2007, The Journal of infectious diseases.
[17] A. Sanchez,et al. Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. , 2007, The Journal of infectious diseases.
[18] A. Kratz,et al. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. , 2004, The New England journal of medicine.
[19] P. Jahrling,et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys , 2003, The Lancet.
[20] P. Jahrling,et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. , 2003, The American journal of pathology.
[21] D. Cook,et al. Ethnic differences in fibrinogen levels: the role of environmental factors and the beta-fibrinogen gene. , 2001, American journal of epidemiology.
[22] H. Cohen,et al. Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[23] J. P. Chen,et al. Hemorrhagic fever virus-induced changes in hemostasis and vascular biology , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[24] R. Swanepoel,et al. Unexpected Ebola virus in a tertiary setting: Clinical and epidemiologic aspects , 2000, Critical care medicine.
[25] E. Ryabchikova,et al. An analysis of features of pathogenesis in two animal models of Ebola virus infection. , 1999, The Journal of infectious diseases.
[26] Sinroku Otatume,et al. Ebola haemorrhagic fever in Zaire , 1996 .
[27] A. Barrett,et al. HAEMATOLOGICAL AND BIOCHEMICAL MONITORING OF EBOLA INFECTION IN RHESUS MONKEYS: IMPLICATIONS FOR PATIENT MANAGEMENT , 1983, The Lancet.
[28] J. F. Wallace,et al. CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL. , 1965, The New England journal of medicine.
[29] Tom Fletcher,et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. , 2015, The New England journal of medicine.
[30] Ebola haemorrhagic fever in Zaire, 1976. , 1978, Bulletin of the World Health Organization.